Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Kohlbrenner

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|March 11, 2016
Aligning needsDennis Ford, William Kohlbrenner
Current Opinion in Biotechnology|December 10, 2003
Evolving therapeutic paradigms for HIV and HCVAkhteruzzaman Molla, William Kohlbrenner
Archives of Biochemistry and Biophysics|February 27, 2004
Hepatitis C NS3 protease inhibition by peptidyl-alpha-ketoamide inhibitors: kinetic mechanism and structureYaya Liu, Vincent S Stoll, Paul L Richardson, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replicationWarren M Kati, Debra Montgomery, Robert Carrick, et al.
Virology|November 3, 2004
Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interactionHongmei Mo, Alex K Konstantinidis, Kent D Stewart, et al.
Biochemistry|July 23, 2003
Investigating the origin of the slow-binding inhibition of HCV NS3 serine protease by a novel substrate based inhibitorYaya Liu, Ayda Saldivar, Joshua Bess, et al.
Journal of Virology|May 7, 2002
In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675Akhteruzzaman Molla, Warren Kati, Robert Carrick, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazinesJohn K Pratt, Pamela Donner, Keith F McDaniel, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocketKent D Stewart, Jeffrey R Huth, Teresa I Ng, et al.
Journal of Medicinal Chemistry|February 20, 2009
Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazinesRolf Wagner, Daniel P Larson, David W A Beno, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|March 11, 2016
Aligning needsDennis Ford, William Kohlbrenner
Current Opinion in Biotechnology|December 10, 2003
Evolving therapeutic paradigms for HIV and HCVAkhteruzzaman Molla, William Kohlbrenner
Archives of Biochemistry and Biophysics|February 27, 2004
Hepatitis C NS3 protease inhibition by peptidyl-alpha-ketoamide inhibitors: kinetic mechanism and structureYaya Liu, Vincent S Stoll, Paul L Richardson, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replicationWarren M Kati, Debra Montgomery, Robert Carrick, et al.
Virology|November 3, 2004
Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interactionHongmei Mo, Alex K Konstantinidis, Kent D Stewart, et al.
Biochemistry|July 23, 2003
Investigating the origin of the slow-binding inhibition of HCV NS3 serine protease by a novel substrate based inhibitorYaya Liu, Ayda Saldivar, Joshua Bess, et al.
Journal of Virology|May 7, 2002
In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675Akhteruzzaman Molla, Warren Kati, Robert Carrick, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazinesJohn K Pratt, Pamela Donner, Keith F McDaniel, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocketKent D Stewart, Jeffrey R Huth, Teresa I Ng, et al.
Journal of Medicinal Chemistry|February 20, 2009
Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazinesRolf Wagner, Daniel P Larson, David W A Beno, et al.
Pageof 1